Fulcrum Therapeutics Inc.

NASDAQ: FULC · Real-Time Price · USD
7.25
0.14 (1.97%)
At close: Jun 06, 2025, 3:59 PM
7.25
-0.07%
After-hours: Jun 06, 2025, 04:04 PM EDT

Fulcrum Therapeutics Statistics

Share Statistics

Fulcrum Therapeutics has 53.98M shares outstanding. The number of shares has increased by -13.15% in one year.

53.98M
-13.15%
0.08%
82.88%
n/a
11,937
2.12%

Short Selling Information

The latest short interest is 4.93M, so 9.13% of the outstanding shares have been sold short.

4.93M
9.13%
11.83%
4.51

Valuation Ratios

The PE ratio is -29.96 and the forward PE ratio is null. Fulcrum Therapeutics's PEG ratio is 0.34.

-29.96
n/a
3.64
4.8
1.2
-116.72
0.34
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Fulcrum Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 22.63, with a Debt / Equity ratio of 0.04.

22.63
22.63
0.04
-0.47
-3.46
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$1,777,777.78
$-216,111.11
45
0.31
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -15.05% in the last 52 weeks. The beta is 2.42, so Fulcrum Therapeutics's price volatility has been higher than the market average.

2.42
-15.05%
4.65
4.36
70.26
561,995

Income Statement

In the last 12 months, Fulcrum Therapeutics had revenue of 80M and earned -9.72M in profits. Earnings per share was -0.17.

80M
78.41M
-21.9M
-9.72M
-18.24M
-19.83M
-0.17
Full Income Statement

Balance Sheet

The company has 58.21M in cash and 8.63M in debt, giving a net cash position of 49.58M.

58.21M
8.63M
49.58M
-519.4M
242.65M
224.46M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.22M and capital expenditures -278K, giving a free cash flow of -2.5M.

-2.22M
-278K
-2.5M
-0.04
Full Cash Flow Statement

Margins

Gross margin is 98.01%, with operating and profit margins of -27.37% and -12.16%.

98.01%
-27.37%
-12.16%
-12.16%
-22.8%
-27.37%
-3.12%

Dividends & Yields

FULC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for FULC is $4, which is -43.7% lower than the current price. The consensus rating is "Hold".

$4
-43.7%
Hold
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

14.02
5